SOFIE Biosciences, an established US manufacturer and developer of radiopharmaceuticals, will be supporting, through companion diagnostic [68Ga]FAPI-46 PET, Yantai LNC Biotechnology’s recently FDA accepted clinical study.
January 17, 2023
· 3 min read